PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsMegestrol acetate
Megestrol acetate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
110 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CachexiaD002100HP_0004326R642872119
Wasting syndromeD0192821871117
AnorexiaD000855HP_0002039R63.0178116
Hiv infectionsD015658EFO_0000764B20131128
Second primary neoplasmsD01660911
Feeding and eating disordersD001068F5011
Feeding behaviorD00524711
Feeding and eating disorders of childhoodD01995911
Precocious pubertyD011629E22.811
Cognitive dysfunctionD060825HP_0001268G31.8411
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Endometrial neoplasmsD016889EFO_00042304174323
LeukemiaD007938C95141318
Precursor cell lymphoblastic leukemia-lymphomaD054198131216
Lymphoid leukemiaD007945C91131115
HyperplasiaD006965EFO_0000536137115
NeoplasmsD009369C8085214
Endometrial hyperplasiaD004714N85.0127114
CarcinomaD002277C80.073110
SyndromeD01357713217
Breast neoplasmsD001943EFO_0003869C501527
Show 37 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hiv wasting syndromeD019247EFO_00073121214
RecurrenceD012008133
Carcinoma in situD002278D09.922
Uterine neoplasmsD014594EFO_0003859C5522
AdenocarcinomaD000230122
VomitingD014839HP_0002013R11.111
NauseaD009325HP_0002018R11.011
Triple negative breast neoplasmsD06472611
PhenylketonuriasD010661E70.011
Brain neoplasmsD001932EFO_0003833C7111
Show 12 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients55
MalnutritionD044342EFO_0008572E40-E46213
Therapeutic equivalencyD01381011
Renal insufficiencyD051437HP_0000083N1911
PharmacokineticsD01059911
Biological availabilityD00168211
AbsorptionD00004211
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Adrenal insufficiencyD00030911
Colorectal neoplasmsD01517911
InfectionsD007239EFO_000054411
Acquired immunodeficiency syndromeD000163EFO_0000765B2011
Immunologic deficiency syndromesD007153HP_0002721D84.911
Failure to thriveD00518311
Fertility preservationD05924711
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 7,760 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2,186 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use